New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Cresilon Raises $25M for Instant Hemostatic Gel

The gel is made from plant-based polymers that stop bleeding on contact without the need to apply pressure.

Cresilon
Cresilon

A recent Vegconomist article discussed a revolutionary wound treatment that has attracted significant investment for further development. The product is Cresilon’s plant-based hemostatic gel called VETIGEL. The company just closed a Series A-4 round of financing to the tune of $25 million. The gel has been used in veterinary applications for both emergency care and surgical procedures.

The fact that VETIGEL is derived from plant materials means it is safer, more biocompatible, and yields fewer side effects. The funding will be used to increase production capacity at Cresilon’s 25,000 sq ft biomanufacturing plant in Brooklyn, and bring the product to the human healthcare market.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts